23 completed. 23 Phase 2, 5 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 23 | Completed 23 |
| Phase 3 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome Rituximab - Steroid-Sensitive Nephrotic Syndrome | Phase 2 | Completed | Children's Hospital of Fudan University | 44 | 2021-04-13 | 2023-07-11 |
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease | Phase 1 / Phase 2 | Completed | University of Aarhus | 57 | 2021-03-25 | 2025-04-11 |
| Personalized Medicine for Membranous Nephropathy Rituximab - Idiopathic Membranous Nephropathy | Phase 2 | Completed | Centre Hospitalier Universitaire de Nice | 68 | 2020-01-14 | 2025-07-25 |
| Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease adalimumab - FSGS, MCD | Phase 2 | Completed | University of Michigan | 7 | 2019-10-02 | 2024-10-30 |
| Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome immunoglobulin IV - Steroid-Dependent Nephrotic Syndrome | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 73 | 2019-04-03 | 2026-10-29 |
| Reduce Immunosuppression With Atmp in NS ChildrEn Cord-blood mesenchymal stromal cells - Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome | Phase 2 | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 20 | 2018-11-02 | 2023-09-28 |
| FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS) CXA-10 - Primary Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Complexa, Inc. | 33 | 2018-04-15 | 2020-08-03 |
| Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) Abatacept, Normal Saline, D5W - Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Bristol-Myers Squibb | 36 | 2016-03-09 | 2021-03-05 |
| Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome Ofatumumab, Rituximab - Nephrotic Syndrome | Phase 2 | Completed | Istituto Giannina Gaslini | 140 | 2015-06-01 | 2020-07-30 |
| A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) Losmapimod - Glomerulosclerosis, Focal Segmental | Phase 2 | Completed | GlaxoSmithKline | 17 | 2014-07-01 | 2017-06-12 |
| Eculizumab in Primary MPGN Eculizumab - Membranoproliferative Glomerulonephritis | Phase 2 | Completed | Mario Negri Institute for Pharmacological Research | 10 | 2014-03-01 | 2018-01-17 |
| Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis RE-021 (Sparsentan), Irbesartan - Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Travere Therapeutics, Inc. | 109 | 2014-03-01 | 2025-05-15 |
| Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients Repository Corticotropin Injection, Placebo - Diabetic Nephropathy | Phase 2 | Completed | Mallinckrodt | 34 | 2012-05-01 | 2019-11-18 |
| IL-2 for Multi Drug Resistant Nephrotic Syndrome Proleukin® - Nephrotic Syndrome | Phase 1 / Phase 2 | Completed | Istituto Giannina Gaslini | 5 | 2012-02-01 | 2015-05-28 |
| Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood Rituximab, Placebo - Childhood Idiopathic Nephrotic Syndrome | Phase 2 / Phase 3 | Completed | University Hospital, Limoges | 26 | 2010-12-01 | 2015-03-23 |
| Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome Tacrolimus - Minimal Change Disease | Phase 2 / Phase 3 | Completed | Seoul National University Hospital | 20 | 2010-06-01 | 2011-08-16 |
| Podocyte Retinoids Isotretinoin - Collapsing Glomerulopathy, Glomerulosclerosis, Focal Segmental | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 12 | 2004-11-26 | 2017-12-13 |
| Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome tacrolimus combined with prednisone - Idiopathic Membranous Nephropathy, Nephrotic Syndrome | Phase 2 / Phase 3 | Completed | Peking University | 2004-11-01 | 2006-08-10 | |
| Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy Sirolimus - Membranous Glomerulonephritis, Lupus Membranous Nepropathy | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 12 | 2002-12-17 | 2017-10-06 |
| Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis NC-503 (Anti-amyloidotic (AA) Agent) - Secondary (AA) Amyloidosis, Rheumatoid Arthritis | Phase 2 / Phase 3 | Completed | Bellus Health Inc. - a GSK company | 150 | 2001-10-01 | 2006-02-14 |
Showing 20 of 23. Sign in to see all of them.
Nephrotic Syndrome (22) · Glomerulosclerosis, Focal Segmental (8) · Proteinuria (8) · Nephrosis, Lipoid (5) · Glomerulonephritis, Membranous (4) · Kidney Diseases (4) · Glomerulonephritis (3) · Fibrosis (2) · Amyloidosis (1) · Arthritis, Rheumatoid (1) · Camurati-Engelmann Syndrome (1) · Diabetic Nephropathies (1) · Familial Mediterranean Fever (1) · Gastrointestinal Diseases (1) · Glomerulonephritis, Membranoproliferative (1)
Female Urogenital Diseases (23) · Female Urogenital Diseases and Pregnancy Complications (23) · Male Urogenital Diseases (23) · Urogenital Diseases (23) · Urologic Diseases (23) · Kidney Diseases (19) · Nephritis (13) · Glomerulonephritis (10) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (8) · Urination Disorders (8) · Urological Manifestations (8) · Immune System Diseases (7) · Autoimmune Diseases (6)
Rituximab (4) · Prednisone (2) · 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide (1) · Abatacept (1) · Adalimumab (1) · Adrenocorticotropic Hormone (1) · CXA-10 (1) · Cyclophosphamide (1) · Cyclosporine (1) · Dalteparin (1) · Dexamethasone (1) · Glucose (1) · Interleukin-2 (1) · Irbesartan (1) · Isotretinoin (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5) · Istituto Giannina Gaslini (2) · Assistance Publique - Hôpitaux de Paris (1) · Bellus Health Inc. - a GSK company (1) · Bristol-Myers Squibb (1) · Centre Hospitalier Universitaire de Nice (1) · Children's Hospital of Fudan University (1) · Complexa, Inc. (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · GlaxoSmithKline (1) · Mallinckrodt (1) · Mario Negri Institute for Pharmacological Research (1) · Peking University (1) · Seoul National University Hospital (1) · Travere Therapeutics, Inc. (1)
United States (12) · Italy (6) · France (4) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · Israel (1) · Lithuania (1) · Netherlands (1) · Poland (1) · Russia (1) · South Korea (1)
Fanfan Hou, MD (1) · Feifei Xu, MD (1) · Fuming Lu, MD (1) · Gian Marco Ghiggeri, MD (1) · Gianmarco Ghiggeri, MD (1) · Howard A Austin, M.D. (1) · Howard Trachtman, M.D. (1) · Jeffrey B Kopp, M.D. (1) · Jianghua Chen, MD (1) · Jiaqi Qian, MD (1)
PMID 39513526, PMID 35224732, PMID 40337980, PMID 17554116, PMID 25457107, PMID 26413873, PMID 28314744, PMID 30361325, PMID 32903623, PMID 32967877, PMID 34544820, PMID 34778952, PMID 35230699, PMID 36223961, PMID 36456193, PMID 36657027, PMID 38724717, PMID 38831932, PMID 39808779, PMID 40478760, PMID 41333097
2015 (1), 2017 (1), 2018 (1)